Download PDF
Am J Perinatol 2014; 31(12): 1037-1042
DOI: 10.1055/s-0034-1370349
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Outcome of Neonatal Chylous Effusions: What Do You Tell the Parents? A 10-Year Experience in a Community Hospital

Bengt-Ola S. Bengtsson
1   Pediatrix Medical Group of California, Neonatal Intensive Care Unit, Community Memorial Hospital of San Buenaventura, Ventura, California
2   Clinical Assistant Professor of Pediatrics, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, California
› Author Affiliations
Further Information

Publication History

07 December 2013

06 January 2014

Publication Date:
24 February 2014 (online)

    Permissions and Reprints

Abstract

Objective The aim of the study was to describe our cases of neonatal chylous effusions and their outcomes and attempt to identify prognostic factors that can aid in the counseling of parents of future patients.

Patients and Methods A retrospective chart review was conducted on all patients with a diagnosis of chylous effusions admitted to our 16-bed community level-3 neonatal intensive care unit (NICU) between June 2003 and November 2013.

Results A total of 10 patients were identified: of these 10 patients, 3 survived and 6 expired. One patient was transferred out and was lost to follow-up. Two-thirds of the survivors had only one site of chylous effusion. The six mortalities were all of gestational age (GA) < 34 weeks; five of the six were low birth weight (LBW) and all six had anasarca/hydrops, two or more sites of chylous effusions, or a genetic syndrome/chromosomal abnormality. The incidence of chylous effusions was 0.03% of all births and these patients constituted 0.37% of the inborn admissions to the NICU.

Conclusions This case series represents a large number of patients considering its single-center community setting. It is prudent to communicate a very guarded prognosis when counseling parents of neonates with chylous effusions. Multiple chylous effusions, hydrops, GA < 34 weeks, LBW, or an accompanying genetic syndrome appear to confer worse prognosis.

Keywords

chylothorax - chyloperitoneum - lymphatic - chylous - outcome
 

  • References

  • 1 Bengtsson B-OS. Neonatal lymphatic (chylous) disorders. Neoreviews 2013; 14: e600-e612
    CrossrefPubMedGoogle Scholar
  • 2 Ergaz Z, Bar-Oz B, Yatsiv I, Arad I. Congenital chylothorax: clinical course and prognostic significance. Pediatr Pulmonol 2009; 44 (8) 806-811
    CrossrefPubMedGoogle Scholar
  • 3 Wasmuth-Pietzuch A, Hansmann M, Bartmann P, Heep A. Congenital chylothorax: lymphopenia and high risk of neonatal infections. Acta Paediatr 2004; 93 (2) 220-224
    CrossrefPubMedGoogle Scholar
  • 4 Panthongviriyakul C, Bines JE. Post-operative chylothorax in children: an evidence-based management algorithm. J Paediatr Child Health 2008; 44 (12) 716-721
    CrossrefPubMedGoogle Scholar
  • 5 Bellini C, Ergaz Z, Radicioni M , et al. Congenital fetal and neonatal visceral chylous effusions: neonatal chylothorax and chylous ascites revisited. A multicenter retrospective study. Lymphology 2012; 45 (3) 91-102
    PubMedGoogle Scholar
  • 6 Caserío S, Gallego C, Martin P, Moral MT, Pallás CR, Galindo A. Congenital chylothorax: from foetal life to adolescence. Acta Paediatr 2010; 99 (10) 1571-1577
    CrossrefPubMedGoogle Scholar
  • 7 Cleveland K, Zook D, Harvey K, Woods RK. Massive chylothorax in small babies. J Pediatr Surg 2009; 44 (3) 546-550
    CrossrefPubMedGoogle Scholar
  • 8 Al-Tawil K, Ahmed G, Al-Hathal M, Al-Jarallah Y, Campbell N. Congenital chylothorax. Am J Perinatol 2000; 17 (3) 121-126
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Das A, Shah PS. Octreotide for the treatment of chylothorax in neonates. Cochrane Database Syst Rev 2010; 8 (9) CD006388
    PubMedGoogle Scholar